EP3329909
Fenflúramín til að nota við að meðhöndla Dravet heilkenni
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
1.5.2014EP published:
17.3.2021EP application number:
18152406.7
EP translation filed:
4.5.2021Grant published:
15.5.2021EPO information:
European Patent Register
Max expiry date:
30.4.2034Expiry date:
30.4.2025
Title:
FENFLURAMINE FOR USE IN THE TREATMENT OF DRAVET SYNDROME
Timeline
Today
1.5.2014EP application
17.3.2021EP Publication
4.5.2021Translation submitted
15.5.2021Registration published
30.4.2025Expires
Owner
Name:
Katholieke Universiteit Leuven KU Leuven Research & DevelopmentAddress:
Waaistraat 6 Box 5105, 3000 Leuven, BE
Name:
University Hospital AntwerpAddress:
Wilrijkstraat 10, 2650 Edegem, BE
Inventor
Name:
Ceulemans, BertenAddress:
2390 Westmalle, BE
Name:
Lagae, LievenAddress:
3050 Oud Heverlee, BE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201313887014Date:
3.5.2013Country:
US
Classification
Categories:
A61K 31/137, A61P 25/08
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 20.5.2021
Expires: 30.4.2022
Payer: Árnason Faktor ehf.
Number: 9
Paid: 5.4.2022
Expires: 30.4.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 12.4.2023
Expires: 30.4.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.4.2024
Expires: 30.4.2025
Payer: Árnason Faktor ehf.